Agilent Technologies (NYSE:A – Get Rating) had its target price increased by stock analysts at Wells Fargo & Company from $130.00 to $135.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Wells Fargo & Company‘s price target points to a potential upside of 1.68% from the company’s previous close.
A number of other research firms have also commented on A. UBS Group began coverage on shares of Agilent Technologies in a research note on Wednesday, July 20th. They issued a “buy” rating and a $139.00 price objective on the stock. KeyCorp dropped their target price on Agilent Technologies from $195.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, June 2nd. StockNews.com upgraded Agilent Technologies from a “buy” rating to a “strong-buy” rating in a report on Wednesday, August 3rd. Truist Financial lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, April 19th. Finally, Citigroup increased their price target on Agilent Technologies from $140.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday. Four analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $153.50.
Agilent Technologies Stock Down 0.8 %
NYSE:A opened at $132.77 on Wednesday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 2.01. The firm has a 50-day simple moving average of $123.31 and a two-hundred day simple moving average of $127.58. Agilent Technologies has a fifty-two week low of $112.52 and a fifty-two week high of $179.57. The firm has a market cap of $39.66 billion, a P/E ratio of 31.99, a P/E/G ratio of 2.74 and a beta of 1.06.
Insiders Place Their Bets
In other Agilent Technologies news, VP Jacob Thaysen sold 5,879 shares of the stock in a transaction dated Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total transaction of $749,160.97. Following the sale, the vice president now owns 88,737 shares of the company’s stock, valued at approximately $11,307,755.91. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, VP Padraig Mcdonnell sold 1,000 shares of the stock in a transaction on Thursday, June 30th. The stock was sold at an average price of $118.62, for a total value of $118,620.00. Following the transaction, the vice president now directly owns 17,826 shares in the company, valued at approximately $2,114,520.12. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Jacob Thaysen sold 5,879 shares of Agilent Technologies stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total value of $749,160.97. Following the completion of the transaction, the vice president now owns 88,737 shares of the company’s stock, valued at $11,307,755.91. The disclosure for this sale can be found here.
Hedge Funds Weigh In On Agilent Technologies
Several hedge funds and other institutional investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC purchased a new position in shares of Agilent Technologies in the 4th quarter worth $31,000. Bromfield Sneider Wealth Advisors acquired a new position in Agilent Technologies during the 2nd quarter valued at approximately $31,000. Riverview Trust Co purchased a new position in Agilent Technologies during the 1st quarter worth approximately $33,000. Glassman Wealth Services raised its position in Agilent Technologies by 47.4% during the fourth quarter. Glassman Wealth Services now owns 230 shares of the medical research company’s stock valued at $37,000 after acquiring an additional 74 shares in the last quarter. Finally, Bank of New Hampshire acquired a new position in shares of Agilent Technologies in the first quarter worth about $38,000.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Target’s Results Cap Upside Potential For Retail Stocks
- Are These 3 Video Game Stocks Now In Play?
- 2 Long-Term EV Plays Trading Under $20
- Exxon, Occidental Petroleum Lead Heavy Month Of Insider Buying
- Why Apple is Primed to Take a Bite Out of Live Sports
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.